PACIRA BIOSCIENCES, INC. Share Price
PACIRA BIOSCIENCES, INC. (PCRX) had Share Price of $25.37 per share as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2026-08-04
- 2026-06-30: Share Price $25.37.
- 2026-03-31: Share Price $22.60.
- 2025-12-31: Share Price $25.88.
- 2025-09-30: Share Price $25.77.
| Period end | Share Price |
|---|---|
| 2026-06-30 | $25.37 10-Q · filed 2026-08-04 |
| 2026-03-31 | $22.60 10-Q · filed 2026-04-30 |
| 2025-12-31 | $25.88 10-K · filed 2026-02-26 |
| 2025-09-30 | $25.77 10-Q · filed 2025-11-06 |
| 2025-06-30 | $23.90 10-Q · filed 2025-08-05 |
| 2025-03-31 | $24.85 10-Q · filed 2025-05-08 |
| 2024-12-31 | $18.84 10-K · filed 2025-02-27 |
| 2024-09-30 | $15.05 10-Q · filed 2024-11-06 |
| 2024-06-28 | $28.61 10-Q · filed 2024-07-30 |
| 2024-05-09 | $29.86 10-Q · filed 2026-08-04 |
| 2024-03-31 | $29.22 10-Q · filed 2024-05-07 |
| 2023-12-31 | $33.74 10-K · filed 2024-02-29 |
| 2023-09-30 | $30.68 10-Q · filed 2023-11-02 |
| 2023-06-30 | $40.07 10-Q · filed 2023-08-02 |
| 2023-03-31 | $40.81 10-Q · filed 2023-05-03 |
| 2022-12-31 | $38.61 10-K · filed 2023-02-28 |
| 2022-09-30 | $53.19 10-Q · filed 2022-11-03 |
| 2022-06-30 | $58.30 10-Q · filed 2022-08-03 |
| 2022-03-31 | $76.32 10-Q · filed 2022-05-04 |
| 2021-12-31 | $60.17 10-K · filed 2022-02-28 |
| 2021-09-30 | $56.00 10-Q · filed 2021-11-03 |
| 2021-06-30 | $60.68 10-Q · filed 2021-08-03 |
| 2021-03-31 | $70.09 10-Q · filed 2021-05-04 |
| 2020-12-31 | $59.84 10-K · filed 2021-03-01 |
| 2020-09-30 | $60.12 10-Q · filed 2020-10-30 |
| 2020-06-30 | $52.47 10-Q · filed 2020-08-06 |
| 2020-03-31 | $33.53 10-Q · filed 2020-05-07 |
| 2019-12-31 | $45.30 10-K · filed 2020-02-21 |
| 2019-09-30 | $38.07 10-Q · filed 2019-11-08 |
| 2019-06-30 | $43.49 10-Q · filed 2019-08-08 |
| 2019-03-31 | $38.06 10-Q · filed 2019-05-02 |
| 2018-12-31 | $43.02 10-K · filed 2019-02-28 |
| 2018-09-30 | $49.15 10-Q · filed 2018-11-01 |
| 2018-06-30 | $32.05 10-Q · filed 2018-08-02 |
| 2018-03-31 | $31.15 10-Q · filed 2018-05-03 |
| 2017-12-31 | $45.65 10-K · filed 2018-02-28 |
| 2017-09-30 | $37.55 10-Q · filed 2017-11-08 |
| 2017-06-30 | $47.70 10-Q · filed 2017-08-02 |
| 2017-03-31 | $45.60 10-Q · filed 2017-05-04 |
| 2016-12-31 | $32.30 10-K · filed 2017-03-01 |
| 2016-09-30 | $34.22 10-Q · filed 2016-11-02 |
| 2016-06-30 | $33.73 10-Q · filed 2016-08-04 |
| 2016-03-31 | $52.98 10-Q · filed 2016-05-02 |
| 2015-12-31 | $76.79 10-K · filed 2016-02-25 |
| 2015-09-30 | $41.10 10-Q · filed 2015-10-27 |
| 2015-06-30 | $70.72 10-Q · filed 2015-07-30 |
| 2015-03-31 | $88.85 10-Q · filed 2015-04-30 |
| 2014-12-31 | $88.66 10-K · filed 2015-02-24 |
| 2014-09-30 | $96.92 10-Q · filed 2014-10-30 |
| 2014-06-30 | $91.86 10-Q · filed 2014-07-31 |
| 2014-04-30 | $64.00 10-K · filed 2017-03-01 |
| 2014-03-31 | $69.99 10-Q · filed 2014-05-01 |
| 2013-12-31 | $57.49 10-K · filed 2014-02-25 |
| 2012-04-30 | $9.75 10-K · filed 2015-02-24 |
| 2012-04-17 | $9.75 10-Q · filed 2012-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |